Follow
saubhagya danasekara
saubhagya danasekara
Unknown affiliation
Verified email at sjp.ac.lk
Title
Cited by
Cited by
Year
Antibody and T cell responses to Sinopharm/BBIBP-CorV in naïve and previously infected individuals in Sri Lanka
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
MedRxiv, 2021.07. 15.21260621, 2021
302021
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
Immunity, inflammation and disease 10 (6), e621, 2022
252022
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
MedRxiv, 2021.10. 14.21265030, 2021
252021
Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection
C Jeewandara, D Guruge, PD Pushpakumara, D Madhusanka, ...
BMC Infectious Diseases 22 (1), 276, 2022
202022
Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka
C Jeewandara, IS Aberathna, S Danasekara, L Gomes, S Fernando, ...
Immunology 167 (2), 263-274, 2022
162022
Seroprevalence of SARS-CoV-2 infection in the Colombo municipality region, Sri Lanka
C Jeewandara, D Guruge, IS Abyrathna, S Danasekara, B Gunasekera, ...
Frontiers in public health 9, 724398, 2021
122021
Antibody and T cell responses to a single dose of the AZD1222/Covishield vaccine in previously SARS-CoV-2 infected and naïve health care workers in Sri Lanka
C Jeewandara, A Kamaladasa, PD Pushpakumara, D Jayathilaka, ...
medRxiv, 2021.04. 09.21255194, 2021
102021
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
C Jeewandara, IS Aberathna, L Gomes, PD Pushpakumara, ...
Immunity, Inflammation and Disease 10 (4), e592, 2022
92022
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
C Jeewandara, S Fernando, PD Pushpakumara, ST Ramu, ...
Scientific Reports 12 (1), 1727, 2022
92022
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
Immunology 167 (2), 275-285, 2022
82022
Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222
D Jayathilaka, C Jeewandara, L Gomes, TTP Jayadas, A Kamaladasa, ...
Clinical and experimental immunology 208 (3), 323-331, 2022
42022
Identification of differences in the magnitude and specificity of SARS-CoV-2 nucleocapsid antibody responses in naturally infected and vaccinated individuals
PD Pushpakumara, C Jeewandara, F Bary, D Madushanka, L Perera, ...
Clinical and Experimental Immunology 215 (3), 268-278, 2024
32024
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka
C Jeewandara, KACS Jayampathi, T Ranasinghe, IS Aberathna, ...
PLOS global public health 2 (7), e0000607, 2022
32022
Comparison of kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222
D Jayathilaka, C Jeewandara, L Gomes, TTP Jayadas, A Kamaladasa, ...
MedRxiv, 2021.07. 14.21260510, 2021
22021
Antibody and T cell responses to Sinopharm/BBIBP-CorV in naïve and previously infected individuals in Sri Lanka (preprint)
C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ...
22021
The burden of dengue in children and risk factors of transmission in nine districts in Sri Lanka
C Jeewandara, MV Karunananda, S Fernando, S Danasekara, ...
Journal of Medical Virology 96 (1), e29394, 2024
12024
Are the rise in childhood obesity rates leading an increase in hospitalizations due to dengue?
C Jeewandara, MV Karunananda, S Fernando, S Danasekara, ...
medRxiv, 2023.09. 14.23295528, 2023
12023
Memory B cell responses at 16 weeks following a single dose of AZD1222/Covishield in Sri Lankan individuals
ST Ramu, C Jeewandara, H Kuruppu, P Pushpakumara, M Harvie, ...
International Journal of Infectious Diseases 116, S63, 2022
12022
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
G Malavige, C Jeewandara, H Fernando, PD Pushpakumara, ...
12021
The burden of dengue and risk factors of transmission in nine districts in Sri Lanka
C Jeewandara, MV Karunananda, S Fernando, S Danasekara, ...
medRxiv, 2023.04. 23.23288986, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20